Steep Hill Inc. (CD0.F)

0.0105 -0.0025 (-19.23%) At close: 08:05AM CEST

Steep Hill Inc.

30 Commercial Road
East York
Toronto, ON M4G 1Z4
Canada

https://www.steephill.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Sameet Kanade CPA, MBA	CEO & Director	139.51k	N/A	N/A
Mr. Robert Tjandra B.Sc., M.B.A.	Founder	77.32k	N/A	N/A
Ms. Patricia Militello	Interim Chief Financial Officer	N/A	N/A	N/A
Mr. Adrian Burke	Vice President of Marketing	N/A	N/A	N/A

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

Steep Hill Inc. does not have significant operations. Previously, it operated as a cannabis-science company in Canada. The company was formerly known as Cannabis Clonal Corporation and changed its name to Steep Hill Inc. in February 2022. The company was founded in 2008 and is based in Toronto, Canada.

Corporate Governance

Steep Hill Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.